idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
ENDOTARGET aimed at investigating the relationship between gut microbiota, intestinal permeability, and systemic endotoxemia to unravel the triggering factors for health-to-disease transition in rheumatic diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), and spondylarthritis (SpA), has achieved significant milestones since its start on January 1st, 2023. The project is funde by the EU with 7 million euros.
ENDOTARGET aimed at investigating the relationship between gut microbiota, intestinal permeability, and systemic endotoxemia to unravel the triggering factors for health-to-disease transition in rheumatic diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), and spondylarthritis (SpA), has achieved significant milestones since its start on January 1st, 2023. The project is funde by the EU with 7 million euros.
Steinbeis Europa Zentrum supports as project partner the communication and dissemination activities of the consortium, as well as the exploitation of the research results.
Led by HUS Helsinki University Hospital, the ENDOTARGET consortium has been actively collaborating through nine interconnected work packages to drive forward research and innovation in the field. Following six months of intensive work, the consortium reconvened from April 11th to 12th in Naples, Italy, hosted by the project partner University of Campania. During this gathering, partners engaged in comprehensive discussions regarding progress and challenges across different work packages.
Some glimpses into the current work of the ENDOTARGET project:
• Scientific Endeavors: The project involves 12 cohorts, with recent efforts focusing on extending in vitro measurements to explore biomarkers and lifestyle factors influencing the transition from health to disease. In particular, blood samples from the Helsinki Businessmen Cohort are being analysed to investigate biomarkers such as TLR4, Zonulin, LBP, I-FABP, sCD14 and S100A8/A9 by using reporter cell assays and Enzyme-linked Immunosorbent Assays (ELISA).
• Mechanistic Studies: Experiments on the inflammatory effects of different bacterial lipopolysaccharides on joint tissue (chondrocyte cell line), including proteomics and RNA-seq analyses, have been conducted. Additionally, the first rat model study with systemic LPS delivery to elucidate the role of LPS in OA progression is ongoing.
• Intervention Studies: Three intervention studies are ongoing, including a Fecal Microbiota Transplantation (FMT) study in Finland with SpA patients, a diet intervention study (TASTY) in Portugal to analyse the effects of the Mediterranean diet in RA patients, and the LARA study in Portugal, Finland and Italy investigating the effect of larazotide in untreated RA patients. The first results are expected at the end of 2024.
• Data Integration and Analysis: The consortium is working towards developing a machine learning (ML) and AI-informed Rheumatic Disease Prediction Tool for clinicians. Efforts are focused currently on extracting, standardising, and harmonising data, which are collected from all the different studies.
• Collaborative Efforts: Partners are actively engaged in work packages focusing on “Ethics, Regulations & GDPR”, “Dissemination, Communication, and Exploitation”, and “Project Management”. The recent in-person exploitation workshop held in Naples facilitated discussions on the anticipated project results and their potential exploitation.
Scientific Publications:
Pazos-Pérez, A.; et al. The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation. Antioxidants. 2024. doi: 10.3390/antiox13010124
Guillán-Fresco, M.; et al. Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes. Nutrients. 2023. doi: 10.3390/nu15132959
Charneca, S.; et al. Beyond Seasoning—The Role of Herbs and Spices in Rheumatic Diseases. Nutrients. 2023. doi: 10.3390/nu15122812
Franco-Trepat, E.; et al. β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine. Antioxidants. 2023. doi: 10.3390/antiox12020371
For more information:
Project Coordinator Team
Helsinki University Hospital (HUS), Helsinki, Finland
Project Coordinator
Kari Eklund (Kari.eklund@hus.fi)
Deputy Project Coordinator
Gonçalo Barreto (Goncalo.barreto@helsinki.fi)
Project Manager
Ana Valkama (Ana.valkama@hus.fi)
Contact Steinbeis Europa Zentrum: Dr. Lena Schleicher, E-Mail: lena.schleicher@steinbeis-europa.de
Project Coordinator
Kari Eklund (Kari.eklund@hus.fi)
http://www.endotargetproject.eu- Project website
http://@ENDOTARGET EU Project - LinkedIn
http://@ENDOTARGET_EU - X
http://@ENDOTARGET- Youtube
Criteria of this press release:
Journalists, Scientists and scholars
Economics / business administration, Medicine, Nutrition / healthcare / nursing
transregional, national
Research projects, Transfer of Science or Research
English
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
